Bartizal Ken 4/A
4/A · Trius Therapeutics Inc · Filed May 28, 2013
Insider Transaction Report
Form 4/AAmended
Bartizal Ken
Chief Development Officer
Transactions
- Sale
Common Stock
2013-05-14$7.85/sh−12,000$94,200→ 110,927 total
Footnotes (2)
- [F1]The reporting person filed a Form 4 reporting a sale of 12,000 shares of common stock on May 14, 2013 which was cancelled by the broker. As of May 14, 2013, the reporting person owned 110,927 shares of common stock.
- [F2]Includes 271 shares, 347 shares and 465 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on 11/18/11, 5/18/12 and 11/20/12, respectively.